Delaying 2nd AstraZeneca vaccine shot by upto 45 weeks improves immune response: Oxford study – ThePrint
A vial of the Covishield vaccine, developed by Oxford-Astrazeneca Plc. and manufactured by Serum Institute of India Ltd (file photo) | Photo: Dhiraj Singh | Bloomberg Text Size: A- A+ Bengaluru: A …
